Copyright Reports & Markets. All rights reserved.

Global Alzheimer Disease Genetic Testing Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Alzheimer Disease Genetic Testing by Type
    • 1.3.1 Overview: Global Alzheimer Disease Genetic Testing Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Alzheimer Disease Genetic Testing Consumption Value Market Share by Type in 2025
    • 1.3.3 Early-Onset Alzheimer Disease
    • 1.3.4 Late-Onset Alzheimer Disease
  • 1.4 Global Alzheimer Disease Genetic Testing Market by Application
    • 1.4.1 Overview: Global Alzheimer Disease Genetic Testing Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Online
    • 1.4.3 Offline
  • 1.5 Global Alzheimer Disease Genetic Testing Market Size & Forecast
  • 1.6 Global Alzheimer Disease Genetic Testing Market Size and Forecast by Region
    • 1.6.1 Global Alzheimer Disease Genetic Testing Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Alzheimer Disease Genetic Testing Market Size by Region, (2021-2032)
    • 1.6.3 North America Alzheimer Disease Genetic Testing Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Alzheimer Disease Genetic Testing Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Alzheimer Disease Genetic Testing Market Size and Prospect (2021-2032)
    • 1.6.6 South America Alzheimer Disease Genetic Testing Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Alzheimer Disease Genetic Testing Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Mega Genomics
    • 2.1.1 Mega Genomics Details
    • 2.1.2 Mega Genomics Major Business
    • 2.1.3 Mega Genomics Alzheimer Disease Genetic Testing Product and Solutions
    • 2.1.4 Mega Genomics Alzheimer Disease Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Mega Genomics Recent Developments and Future Plans
  • 2.2 Blueprint Genetics
    • 2.2.1 Blueprint Genetics Details
    • 2.2.2 Blueprint Genetics Major Business
    • 2.2.3 Blueprint Genetics Alzheimer Disease Genetic Testing Product and Solutions
    • 2.2.4 Blueprint Genetics Alzheimer Disease Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Blueprint Genetics Recent Developments and Future Plans
  • 2.3 Generi-Biotech
    • 2.3.1 Generi-Biotech Details
    • 2.3.2 Generi-Biotech Major Business
    • 2.3.3 Generi-Biotech Alzheimer Disease Genetic Testing Product and Solutions
    • 2.3.4 Generi-Biotech Alzheimer Disease Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Generi-Biotech Recent Developments and Future Plans
  • 2.4 RxHomeTest
    • 2.4.1 RxHomeTest Details
    • 2.4.2 RxHomeTest Major Business
    • 2.4.3 RxHomeTest Alzheimer Disease Genetic Testing Product and Solutions
    • 2.4.4 RxHomeTest Alzheimer Disease Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 RxHomeTest Recent Developments and Future Plans
  • 2.5 Kashi Labs
    • 2.5.1 Kashi Labs Details
    • 2.5.2 Kashi Labs Major Business
    • 2.5.3 Kashi Labs Alzheimer Disease Genetic Testing Product and Solutions
    • 2.5.4 Kashi Labs Alzheimer Disease Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Kashi Labs Recent Developments and Future Plans
  • 2.6 23andMe
    • 2.6.1 23andMe Details
    • 2.6.2 23andMe Major Business
    • 2.6.3 23andMe Alzheimer Disease Genetic Testing Product and Solutions
    • 2.6.4 23andMe Alzheimer Disease Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 23andMe Recent Developments and Future Plans
  • 2.7 LabCorp
    • 2.7.1 LabCorp Details
    • 2.7.2 LabCorp Major Business
    • 2.7.3 LabCorp Alzheimer Disease Genetic Testing Product and Solutions
    • 2.7.4 LabCorp Alzheimer Disease Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 LabCorp Recent Developments and Future Plans
  • 2.8 Empower DX
    • 2.8.1 Empower DX Details
    • 2.8.2 Empower DX Major Business
    • 2.8.3 Empower DX Alzheimer Disease Genetic Testing Product and Solutions
    • 2.8.4 Empower DX Alzheimer Disease Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Empower DX Recent Developments and Future Plans
  • 2.9 SolGent
    • 2.9.1 SolGent Details
    • 2.9.2 SolGent Major Business
    • 2.9.3 SolGent Alzheimer Disease Genetic Testing Product and Solutions
    • 2.9.4 SolGent Alzheimer Disease Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 SolGent Recent Developments and Future Plans
  • 2.10 CapitalBio
    • 2.10.1 CapitalBio Details
    • 2.10.2 CapitalBio Major Business
    • 2.10.3 CapitalBio Alzheimer Disease Genetic Testing Product and Solutions
    • 2.10.4 CapitalBio Alzheimer Disease Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 CapitalBio Recent Developments and Future Plans
  • 2.11 Genex Diagnostics
    • 2.11.1 Genex Diagnostics Details
    • 2.11.2 Genex Diagnostics Major Business
    • 2.11.3 Genex Diagnostics Alzheimer Disease Genetic Testing Product and Solutions
    • 2.11.4 Genex Diagnostics Alzheimer Disease Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Genex Diagnostics Recent Developments and Future Plans
  • 2.12 Sansure
    • 2.12.1 Sansure Details
    • 2.12.2 Sansure Major Business
    • 2.12.3 Sansure Alzheimer Disease Genetic Testing Product and Solutions
    • 2.12.4 Sansure Alzheimer Disease Genetic Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Sansure Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Alzheimer Disease Genetic Testing Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Alzheimer Disease Genetic Testing by Company Revenue
    • 3.2.2 Top 3 Alzheimer Disease Genetic Testing Players Market Share in 2025
    • 3.2.3 Top 6 Alzheimer Disease Genetic Testing Players Market Share in 2025
  • 3.3 Alzheimer Disease Genetic Testing Market: Overall Company Footprint Analysis
    • 3.3.1 Alzheimer Disease Genetic Testing Market: Region Footprint
    • 3.3.2 Alzheimer Disease Genetic Testing Market: Company Product Type Footprint
    • 3.3.3 Alzheimer Disease Genetic Testing Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Alzheimer Disease Genetic Testing Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Alzheimer Disease Genetic Testing Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Alzheimer Disease Genetic Testing Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Alzheimer Disease Genetic Testing Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Alzheimer Disease Genetic Testing Consumption Value by Type (2021-2032)
  • 6.2 North America Alzheimer Disease Genetic Testing Market Size by Application (2021-2032)
  • 6.3 North America Alzheimer Disease Genetic Testing Market Size by Country
    • 6.3.1 North America Alzheimer Disease Genetic Testing Consumption Value by Country (2021-2032)
    • 6.3.2 United States Alzheimer Disease Genetic Testing Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Alzheimer Disease Genetic Testing Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Alzheimer Disease Genetic Testing Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Alzheimer Disease Genetic Testing Consumption Value by Type (2021-2032)
  • 7.2 Europe Alzheimer Disease Genetic Testing Consumption Value by Application (2021-2032)
  • 7.3 Europe Alzheimer Disease Genetic Testing Market Size by Country
    • 7.3.1 Europe Alzheimer Disease Genetic Testing Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Alzheimer Disease Genetic Testing Market Size and Forecast (2021-2032)
    • 7.3.3 France Alzheimer Disease Genetic Testing Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Alzheimer Disease Genetic Testing Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Alzheimer Disease Genetic Testing Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Alzheimer Disease Genetic Testing Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Alzheimer Disease Genetic Testing Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Alzheimer Disease Genetic Testing Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Alzheimer Disease Genetic Testing Market Size by Region
    • 8.3.1 Asia-Pacific Alzheimer Disease Genetic Testing Consumption Value by Region (2021-2032)
    • 8.3.2 China Alzheimer Disease Genetic Testing Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Alzheimer Disease Genetic Testing Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Alzheimer Disease Genetic Testing Market Size and Forecast (2021-2032)
    • 8.3.5 India Alzheimer Disease Genetic Testing Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Alzheimer Disease Genetic Testing Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Alzheimer Disease Genetic Testing Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Alzheimer Disease Genetic Testing Consumption Value by Type (2021-2032)
  • 9.2 South America Alzheimer Disease Genetic Testing Consumption Value by Application (2021-2032)
  • 9.3 South America Alzheimer Disease Genetic Testing Market Size by Country
    • 9.3.1 South America Alzheimer Disease Genetic Testing Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Alzheimer Disease Genetic Testing Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Alzheimer Disease Genetic Testing Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Alzheimer Disease Genetic Testing Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Alzheimer Disease Genetic Testing Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Alzheimer Disease Genetic Testing Market Size by Country
    • 10.3.1 Middle East & Africa Alzheimer Disease Genetic Testing Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Alzheimer Disease Genetic Testing Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Alzheimer Disease Genetic Testing Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Alzheimer Disease Genetic Testing Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Alzheimer Disease Genetic Testing Market Drivers
  • 11.2 Alzheimer Disease Genetic Testing Market Restraints
  • 11.3 Alzheimer Disease Genetic Testing Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Alzheimer Disease Genetic Testing Industry Chain
  • 12.2 Alzheimer Disease Genetic Testing Upstream Analysis
  • 12.3 Alzheimer Disease Genetic Testing Midstream Analysis
  • 12.4 Alzheimer Disease Genetic Testing Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Alzheimer Disease Genetic Testing market size was valued at US$ 207 million in 2025 and is forecast to a readjusted size of US$ 650 million by 2032 with a CAGR of 18.0% during review period.
    Alzheimer"s disease is a neurodegenerative disorder that affects memory, cognitive functions, and behavior. While there is no cure for Alzheimer"s disease, early detection and treatment can help slow the progression of the disease. Genetic testing can be a useful tool in identifying individuals who may be at higher risk of developing Alzheimer"s disease.
    This report is a detailed and comprehensive analysis for global Alzheimer Disease Genetic Testing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Alzheimer Disease Genetic Testing market size and forecasts, in consumption value ($ Million), 2021-2032
    Global Alzheimer Disease Genetic Testing market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
    Global Alzheimer Disease Genetic Testing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
    Global Alzheimer Disease Genetic Testing market shares of main players, in revenue ($ Million), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Alzheimer Disease Genetic Testing
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Alzheimer Disease Genetic Testing market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Mega Genomics, Blueprint Genetics, Generi-Biotech, RxHomeTest, Kashi Labs, 23andMe, LabCorp, Empower DX, SolGent, CapitalBio, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Alzheimer Disease Genetic Testing market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Early-Onset Alzheimer Disease
    Late-Onset Alzheimer Disease
    Market segment by Application
    Online
    Offline
    Market segment by players, this report covers
    Mega Genomics
    Blueprint Genetics
    Generi-Biotech
    RxHomeTest
    Kashi Labs
    23andMe
    LabCorp
    Empower DX
    SolGent
    CapitalBio
    Genex Diagnostics
    Sansure
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Alzheimer Disease Genetic Testing product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Alzheimer Disease Genetic Testing, with revenue, gross margin, and global market share of Alzheimer Disease Genetic Testing from 2021 to 2026.
    Chapter 3, the Alzheimer Disease Genetic Testing competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Alzheimer Disease Genetic Testing market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Alzheimer Disease Genetic Testing.
    Chapter 13, to describe Alzheimer Disease Genetic Testing research findings and conclusion.

    Buy now